Clinical efficacy of carumonam.


Carumonam is a new N-sulfo-beta-lactam antibiotic active against aerobic Gram-negative bacteria. An open study was carried out to evaluate the efficacy, safety and tolerance of carumonam with either 1 g t.i.d. (group A) or 2 g t.i.d. (group B) in bacterial septicaemia or severe sepsis. A total of 24 patients (14 men and 10 women) were included in the study… (More)


Cite this paper

@article{Drabu1988ClinicalEO, title={Clinical efficacy of carumonam.}, author={Yasmin J Drabu and S Mehtar and P H Blakemore}, journal={Drugs under experimental and clinical research}, year={1988}, volume={14 10}, pages={665-7} }